Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation.

Trimpert C, Wesche D, de Groot T, Pimentel Rodriguez MM, Wong V, van den Berg DTM, Cheval L, Ariza CA, Doucet A, Stagljar I, Deen PMT.

PLoS One. 2017 Sep 20;12(9):e0183774. doi: 10.1371/journal.pone.0183774. eCollection 2017.

2.

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Velde H, Richardson PG; TOURMALINE-MM1 Study Group.

N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282.

3.

Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study.

Bouchard J, Malhotra R, Shah S, Kao YT, Vaida F, Gupta A, Berg DT, Grinnell BW, Stofan B, Tolwani AJ, Mehta RL.

PLoS One. 2015 Mar 19;10(3):e0120770. doi: 10.1371/journal.pone.0120770. eCollection 2015.

4.

Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus.

Trimpert C, van den Berg DT, Fenton RA, Klussmann E, Deen PM.

Nephrol Dial Transplant. 2012 Dec;27(12):4389-97. doi: 10.1093/ndt/gfs292. Epub 2012 Jul 9.

PMID:
22778181
5.

The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review.

van den Berg DT, Deinum J, Postma CT, van der Wilt GJ, Riksen NP.

Eur J Heart Fail. 2012 Jul;14(7):773-81. doi: 10.1093/eurjhf/hfs037. Epub 2012 Mar 28. Review.

6.

Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice.

Rajashekhar G, Gupta A, Marin A, Friedrich J, Willuweit A, Berg DT, Cramer MS, Sandusky GE, Sutton TA, Basile DP, Grinnell BW, Clauss M.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F703-12. doi: 10.1152/ajprenal.00558.2011. Epub 2011 Nov 30.

7.

The role of nurses in the recognition and treatment of patients with sepsis in the emergency department: a prospective before-and-after intervention study.

Tromp M, Hulscher M, Bleeker-Rovers CP, Peters L, van den Berg DT, Borm GF, Kullberg BJ, van Achterberg T, Pickkers P.

Int J Nurs Stud. 2010 Dec;47(12):1464-73. doi: 10.1016/j.ijnurstu.2010.04.007. Epub 2010 May 21.

PMID:
20494356
8.

Soluble thrombomodulin protects ischemic kidneys.

Sharfuddin AA, Sandoval RM, Berg DT, McDougal GE, Campos SB, Phillips CL, Jones BE, Gupta A, Grinnell BW, Molitoris BA.

J Am Soc Nephrol. 2009 Mar;20(3):524-34. doi: 10.1681/ASN.2008060593. Epub 2009 Jan 28.

9.

Distinct functions of activated protein C differentially attenuate acute kidney injury.

Gupta A, Gerlitz B, Richardson MA, Bull C, Berg DT, Syed S, Galbreath EJ, Swanson BA, Jones BE, Grinnell BW.

J Am Soc Nephrol. 2009 Feb;20(2):267-77. doi: 10.1681/ASN.2008030294. Epub 2008 Dec 17.

10.

Activated protein C modulates chemokine response and tissue injury in experimental sepsis.

Sharma GR, Gerlitz B, Berg DT, Cramer MS, Jakubowski JA, Galbreath EJ, Heuer JG, Grinnell BW.

Adv Exp Med Biol. 2008;614:83-91. doi: 10.1007/978-0-387-74911-2_10.

PMID:
18290317
11.

Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.

Richardson MA, Gupta A, O'Brien LA, Berg DT, Gerlitz B, Syed S, Sharma GR, Cramer MS, Heuer JG, Galbreath EJ, Grinnell BW.

J Pharmacol Exp Ther. 2008 Apr;325(1):17-26. doi: 10.1124/jpet.107.130609. Epub 2008 Jan 8.

PMID:
18182560
12.

Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP.

Nat Med. 2007 Nov;13(11):1349-58. Epub 2007 Nov 4.

PMID:
17982464
13.

Activated protein C decreases tumor necrosis factor related apoptosis-inducing ligand by an EPCR- independent mechanism involving Egr-1/Erk-1/2 activation.

O'Brien LA, Richardson MA, Mehrbod SF, Berg DT, Gerlitz B, Gupta A, Grinnell BW.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2634-41. Epub 2007 Oct 11.

PMID:
17932312
14.

Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11.

Berg DT, Gupta A, Richardson MA, O'Brien LA, Calnek D, Grinnell BW.

J Biol Chem. 2007 Dec 21;282(51):36837-44. Epub 2007 Oct 9.

15.

Activated protein C suppresses adrenomedullin and ameliorates lipopolysaccharide-induced hypotension.

Gupta A, Berg DT, Gerlitz B, Richardson MA, Galbreath E, Syed S, Sharma AC, Lowry SF, Grinnell BW.

Shock. 2007 Oct;28(4):468-76.

PMID:
17558353
16.

Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2.

Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW.

Am J Physiol Renal Physiol. 2007 Jul;293(1):F245-54. Epub 2007 Apr 4.

17.

Role of protein C in renal dysfunction after polymicrobial sepsis.

Gupta A, Berg DT, Gerlitz B, Sharma GR, Syed S, Richardson MA, Sandusky G, Heuer JG, Galbreath EJ, Grinnell BW.

J Am Soc Nephrol. 2007 Mar;18(3):860-7. Epub 2007 Feb 14.

18.

Capecitabine: a new adjuvant option for colorectal cancer.

Berg DT.

Clin J Oncol Nurs. 2006 Aug;10(4):479-86. Review.

PMID:
16927901
19.

FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis.

Berg DT, Gerlitz B, Sharma GR, Richardson MA, Stephens EJ, Grubbs RL, Holmes KC, Fynboe K, Montani D, Cramer MS, Engle SD, Jakubowski JA, Heuer JG, Grinnell BW.

Clin Vaccine Immunol. 2006 Mar;13(3):426-32.

20.

NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells.

Du Y, Chen X, Wei X, Bales KR, Berg DT, Paul SM, Farlow MR, Maloney B, Ge YW, Lahiri DK.

Brain Res Mol Brain Res. 2005 May 20;136(1-2):177-88.

PMID:
15893602
21.

Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transforming growth factor-beta.

Berg DT, Myers LJ, Richardson MA, Sandusky G, Grinnell BW.

J Biol Chem. 2005 Apr 15;280(15):14943-7. Epub 2005 Feb 16.

22.

Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis.

Heuer JG, Sharma GR, Gerlitz B, Zhang T, Bailey DL, Ding C, Berg DT, Perkins D, Stephens EJ, Holmes KC, Grubbs RL, Fynboe KA, Chen YF, Grinnell B, Jakubowski JA.

Crit Care Med. 2004 Jul;32(7):1570-8.

PMID:
15241104
23.

Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Berg DT, Gerlitz B, Shang J, Smith T, Santa P, Richardson MA, Kurz KD, Grinnell BW, Mace K, Jones BE.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4423-8. Epub 2003 Apr 1.

24.

Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads.

Sandusky G, Berg DT, Richardson MA, Myers L, Grinnell BW.

J Biol Chem. 2002 Dec 20;277(51):49815-9. Epub 2002 Oct 28.

25.

Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.

Chen YQ, Sloan-Lancaster J, Berg DT, Richardson MA, Grinnell B, Tseng-Crank J.

Thromb Haemost. 2001 Dec;86(6):1563-72.

PMID:
11776328
26.

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, Lee EJ, Moore JO, Powell BL, Baer MR, Bloomfield CD, Schiffer CA.

Blood. 2001 Aug 1;98(3):548-53.

27.

Therapeutic options for treating advanced colorectal cancer.

Berg DT, Lilienfeld C.

Clin J Oncol Nurs. 2000 Sep-Oct;4(5):209-16. Review.

PMID:
11111452
28.

17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway.

Richardson MA, Berg DT, Calnek DS, Ciaccia AV, Joyce DE, Grinnell BW.

Endocrinology. 2000 Oct;141(10):3908-11.

PMID:
11014248
29.

Colorectal cancer in a 43-year-old man.

Engelking C, Sauerland C, Vanoni FR, Rychcik J, Hill GJ, Berg DT, Lilienfeld C.

Cancer Pract. 1999 May-Jun;7(3):109-13. No abstract available.

PMID:
10352072
30.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ.

Cancer Res. 1998 Sep 15;58(18):4173-9.

31.

New chemotherapy treatment options and implications for nursing care.

Berg DT.

Oncol Nurs Forum. 1997 Jan-Feb;24(1 Suppl):5-12. Review. Erratum in: Oncol Nurs Forum 1997 Apr;24(3):442.

PMID:
9010860
32.

Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator.

Berg DT, Wiley MR, Grinnell BW.

Science. 1996 Sep 6;273(5280):1389-91.

PMID:
8703074
33.

Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol.

Richardson MA, Berg DT, Johnston PA, McClure D, Grinnell BW.

J Lipid Res. 1996 May;37(5):1162-6.

34.

Trans-repressor BEF-1 phosphorylation. A potential control mechanism for human ApoE gene regulation.

Berg DT, Calnek DS, Grinnell BW.

J Biol Chem. 1996 Mar 1;271(9):4589-92.

35.

Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells.

Grinnell BW, Berg DT.

Am J Physiol. 1996 Feb;270(2 Pt 2):H603-9.

PMID:
8779836
36.
37.

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiffer CA.

N Engl J Med. 1995 Jun 22;332(25):1671-7.

38.

Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.

Van den Berg DT, de Kloet ER, de Jong W.

Am J Physiol. 1994 Dec;267(6 Pt 1):E927-33.

PMID:
7810636
39.

Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming.

Van den Berg DT, de Jong W, de Kloet ER.

Am J Physiol. 1994 Dec;267(6 Pt 1):E921-6.

PMID:
7810635
40.

Brain mineralocorticoid receptor function.

de Kloet ER, Rots NY, van den Berg DT, Oitzl MS.

Ann N Y Acad Sci. 1994 Nov 30;746:8-20; discussion 20-1, 64-7. Review. No abstract available.

PMID:
7825924
42.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E 3rd.

N Engl J Med. 1994 Oct 6;331(14):896-903.

43.

Brain mineralocorticoid receptor diversity: functional implications.

de Kloet ER, Sutanto W, van den Berg DT, Carey MP, van Haarst AD, Hornsby CD, Meijer OC, Rots NY, Oitzl MS.

J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):183-90. Review.

PMID:
8274434
44.

High-level expression of secreted proteins from cells adapted to serum-free suspension culture.

Berg DT, McClure DB, Grinnell BW.

Biotechniques. 1993 Jun;14(6):972-8.

PMID:
8333965
45.

Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.

Berg DT, Burck PJ, Berg DH, Grinnell BW.

Blood. 1993 Mar 1;81(5):1312-22.

46.
47.

5' sequence of vesicular stomatitis virus N-gene confers selective translation of mRNA.

Berg DT, Grinnell BW.

Biochem Biophys Res Commun. 1992 Dec 30;189(3):1585-90.

PMID:
1336374
48.

E1a-responsive mammalian host/vector system for the stable high-level expression of secreted proteins.

Berg DT, McClure DB, Grinnell BW.

Nucleic Acids Res. 1992 Oct 25;20(20):5485-6. No abstract available.

49.

Corticosteroid receptor plasticity in the central nervous system of various rat models.

Sutanto W, Oitzl MS, Rots NY, Schöbitz B, Van den Berg DT, Van Dijken HH, Mos J, Cools AR, Tilders FJ, Koolhaas JM, et al.

Endocr Regul. 1992 Sep;26(3):111-8.

PMID:
1339189
50.

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM.

J Clin Oncol. 1992 Jun;10(6):948-53.

PMID:
1588374

Supplemental Content

Support Center